DSG1: A Drug Target / Disease Biomarker (G1828)

Target Name: DSG1

NCBI ID: G1828

DSG1

DSG1: A Drug Target / Disease Biomarker

DSG1 (doublecortin) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a 26-kDa protein that is composed of two distinct regions: an N-terminus and a C-terminus. The N-terminus of DSG1 contains a putative nuclear localization signal (NLS) that is involved in the protein's nuclear transport and stability. The C-terminus of DSG1 contains a conserved region that is involved in its stability and interactions with other proteins.

DSG1 is involved in various physiological processes in the body, including cell signaling, neurotransmission, and insulin secretion. It has been shown to play a role in the regulation of glucose metabolism, insulin sensitivity, and inflammation.

DSG1 has also been shown to be a potential drug target in the treatment of various diseases, including diabetes, cancer, and neurodegenerative diseases. The NLS of DSG1 has been identified as a potential drug target, and various studies have shown that inhibition of the NLS can lead to increased insulin sensitivity and improved glucose metabolism in diabetes patients.

In addition to its potential as a drug target, DSG1 has also been shown to be a biomarker for various diseases, including cancer and neurodegenerative diseases. The stability and function of DSG1 have been shown to be altered in various diseases, including cancer, and these changes have been associated with the development and progression of these diseases.

DSG1 has also been shown to play a role in the regulation of inflammation, and its expression has been shown to be increased in various inflammatory conditions, including cancer and neurodegenerative diseases. This suggests that DSG1 may be a potential therapeutic target for the treatment of inflammatory diseases.

In conclusion, DSG1 is a protein that is involved in various physiological processes in the body, including cell signaling, neurotransmission, and insulin secretion. It has also been shown to play a role in the regulation of glucose metabolism, insulin sensitivity, and inflammation. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for various diseases. Further research is needed to fully understand the role of DSG1 in the treatment of diseases and to develop safe and effective drugs that target this protein.

Protein Name: Desmoglein 1

Functions: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion

The "DSG1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DSG1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets